A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...

The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery ...

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

Facing a prostate cancer diagnosis can feel overwhelming, but you don’t have to navigate it alone. When prostate cancer is caught early, there are several treatment options to consider, and in some ...

ADC targeting both PSMA and STEAP1 with a topoisomerase payload showed a 15-month PFS signal in heavily pretreated prostate ...

Proton therapy is a form of radiation that reduces the total amount of radiation to the tissues surrounding the tumor, which could potentially lead to fewer side effects. If you have prostate cancer, ...

One in eight men in the United States will develop prostate cancer as they get older. It’s the most common cancer in men in this country besides skin cancer. Worldwide, it is second only to lung ...

Every two minutes, a man in the U.S. is diagnosed with prostate cancer. Every 15 minutes, another dies of it. Prostate cancer disproportionately affects Black men. In D.C., more die from prostate ...

New Jersey hospitals expand prostate cancer treatment with robotics, proton therapy and precision medicine innovations.